1066 related articles for article (PubMed ID: 18251980)
1. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis.
Zhang FK; Jia JD; Wang BE
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):288-91. PubMed ID: 15138128
[TBL] [Abstract][Full Text] [Related]
3. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.
Kim WR; Poterucha JJ; Jorgensen RA; Batts KP; Homburger HA; Dickson ER; Krom RA; Wiesner RH; Lindor KD
Hepatology; 1997 Jul; 26(1):22-6. PubMed ID: 9214447
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis.
Invernizzi P; Crosignani A; Battezzati PM; Covini G; De Valle G; Larghi A; Zuin M; Podda M
Hepatology; 1997 May; 25(5):1090-5. PubMed ID: 9141422
[TBL] [Abstract][Full Text] [Related]
5. Antimitochondrial antibody-negative primary biliary cirrhosis.
Lacerda MA; Ludwig J; Dickson ER; Jorgensen RA; Lindor KD
Am J Gastroenterol; 1995 Feb; 90(2):247-9. PubMed ID: 7847294
[TBL] [Abstract][Full Text] [Related]
6. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens.
Miyakawa H; Tanaka A; Kikuchi K; Matsushita M; Kitazawa E; Kawaguchi N; Fujikawa H; Gershwin ME
Hepatology; 2001 Aug; 34(2):243-8. PubMed ID: 11481607
[TBL] [Abstract][Full Text] [Related]
7. In vitro production of antimitochondrial antibody by peripheral blood mononuclear cells in patients with primary biliary cirrhosis.
Ishikawa T; Kakumu S; Wakita T; Takayanagi M; Yoshioka K
J Clin Lab Immunol; 1991 May; 35(1):17-25. PubMed ID: 1668286
[TBL] [Abstract][Full Text] [Related]
8. Antimitochondrial antibody-negative primary biliary cirrhosis.
Mendes F; Lindor KD
Gastroenterol Clin North Am; 2008 Jun; 37(2):479-84, viii. PubMed ID: 18499032
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic features of primary biliary cirrhosis in AMA-positive and AMA-negative patients.
Fujioka S; Yamamoto K; Okamoto R; Miyake M; Ujike K; Shimada N; Terada R; Miyake Y; Nakajima H; Piao CY; Iwasaki Y; Tanimizu M; Tsuji T
Endoscopy; 2002 Apr; 34(4):318-21. PubMed ID: 11932789
[TBL] [Abstract][Full Text] [Related]
10. Primary biliary cirrhosis and hepatitis C virus infection.
Floreani A; Baragiotta A; Leone MG; Baldo V; Naccarato R
Am J Gastroenterol; 2003 Dec; 98(12):2757-62. PubMed ID: 14687829
[TBL] [Abstract][Full Text] [Related]
11. [The value of antimitochondrial antibody and its subtypes in the diagnosis of primary biliary cirrhosis].
Yao DK; Xie WF; Chen WZ; Liu HY; Tu XQ; Fan LY
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):9-11. PubMed ID: 15670482
[TBL] [Abstract][Full Text] [Related]
12. Clinical correlation of antimitochondrial antibodies.
Zuber MA; Recktenwald C
Eur J Med Res; 2003 Feb; 8(2):61-70. PubMed ID: 12626283
[TBL] [Abstract][Full Text] [Related]
13. Antimitochondrial antibody profiles: are they valid prognostic indicators in primary biliary cirrhosis?
Joshi S; Cauch-Dudek K; Heathcote EJ; Lindor K; Jorgensen R; Klein R
Am J Gastroenterol; 2002 Apr; 97(4):999-1002. PubMed ID: 12003438
[TBL] [Abstract][Full Text] [Related]
14. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis.
Tanaka A; Nezu S; Uegaki S; Mikami M; Okuyama S; Kawamura N; Aiso M; Gershwin ME; Takahashi S; Selmi C; Takikawa H
Ann N Y Acad Sci; 2007 Jun; 1107():259-70. PubMed ID: 17804554
[TBL] [Abstract][Full Text] [Related]
16. [Immunological characteristics of primary biliary cirrhosis patients].
Yan HP; Zhuang H; Liu YM; Feng X; Tan YF; Liu Y; Zhang X; Zhao CH
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):12-6. PubMed ID: 15670483
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and pathological features of primary biliary cirrhotic patients with negative anti-mitochondria antibody].
Wang QX; Shen L; Chen XY; Qiu DK; Ma X
Zhonghua Gan Zang Bing Za Zhi; 2011 May; 19(5):340-4. PubMed ID: 21645440
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic value of anti-mitochondrial antibodies, especially in primary biliary cirrhosis.
Tanaka A; Miyakawa H; Luketic VA; Kaplan M; Storch WB; Gershwin ME
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):295-9. PubMed ID: 12030434
[TBL] [Abstract][Full Text] [Related]
19. Detection of novel non-M2-related antimitochondrial antibodies in patients with anti-M2 negative primary biliary cirrhosis.
Feuchtinger M; Christ S; Preuss B; Dengjel J; Duman S; Stevanovic S; Klein R
Gut; 2009 Jul; 58(7):983-9. PubMed ID: 19336422
[TBL] [Abstract][Full Text] [Related]
20. PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis.
Granito A; Yang WH; Muratori L; Lim MJ; Nakajima A; Ferri S; Pappas G; Quarneti C; Bianchi FB; Bloch DB; Muratori P
Am J Gastroenterol; 2010 Jan; 105(1):125-31. PubMed ID: 19861957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]